about
The role of epidermal growth factor-like module containing mucin-like hormone receptor 2 in human cancersCurrent Applications of MRI-Guided Laser Interstitial Thermal Therapy in the Treatment of Brain Neoplasms and Epilepsy: A Radiologic and Neurosurgical OverviewProportional upregulation of CD97 isoforms in glioblastoma and glioblastoma-derived brain tumor initiating cellsOverexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patientsFactors influencing overall survival rates for patients with pineocytoma.Gross total resection improves overall survival in children with choroid plexus carcinoma.The role of magnetic resonance-guided laser ablation in neurooncology.Laser Ablation of Newly Diagnosed Malignant Gliomas: a Meta-Analysis.Risk factors for postoperative cerebrospinal fluid leak and meningitis after expanded endoscopic endonasal surgery.Immunocompetent murine models for the study of glioblastoma immunotherapyStable luciferase expression does not alter immunologic or in vivo growth properties of GL261 murine glioma cellsEpilepsy surgery failure in children: a quantitative and qualitative analysisPI3K pathway inhibitors: potential prospects as adjuncts to vaccine immunotherapy for glioblastoma.Magnetic Resonance-Guided Laser Ablation for the Treatment of Recurrent Dural-Based Lesions: A Series of Five Cases.Association of morbidity with extent of resection and cavernous sinus invasion in sphenoid wing meningiomasNa⁺/K⁺-ATPase β2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cells.Tumor control after surgery and radiotherapy for pineocytoma.Pathology of pineal parenchymal tumors.Current management of choroid plexus carcinomas.Intraventricular neurocytomas: a systematic review of stereotactic radiosurgery and fractionated conventional radiotherapy for residual or recurrent tumors.Tumors of the anterior skull base.Effects of adjuvant chemotherapy and radiation on overall survival in children with choroid plexus carcinoma.The role of 5-aminolevulinic acid in brain tumor surgery: a systematic review.Management of Atypical and Anaplastic Meningiomas.The limited capacity of malignant glioma-derived exosomes to suppress peripheral immune effectors.Treatment of adult and pediatric high-grade gliomas with Withaferin A: antitumor mechanisms and future perspectives.Epidermal growth factor-like module containing mucin-like hormone receptor 2 expression in gliomas.Pathogens and glioma: a history of unexpected discoveries ushering in novel therapy.Visual Deficit From Laser Interstitial Thermal Therapy for Temporal Lobe Epilepsy: Anatomical Considerations.Mini supraorbital approach to inferior frontal lobe cavernous malformations: case series.Subtemporal-medial transpetrous (Kawase) approach for anterior inferior cerebellar artery aneurysm clipping: operative 3-dimensional video.Effects of temporal lobectomy on consciousness-impairing and consciousness-sparing seizures in children.A meta-analysis of tumor control rates and treatment-related morbidity for patients with glomus jugulare tumors.Placement of a subdural evacuating port system for management of iatrogenic hyperacute subdural hemorrhage following intracranial monitor placement.Facial neuroma masquerading as acoustic neuroma.Brainstem cavernous malformations: surgical results in 104 patients and a proposed grading system to predict neurological outcomes.Quantitative Volumetric Analysis Following Magnetic Resonance-Guided Laser Interstitial Thermal Ablation of Cerebellar Metastases.Subdural hematoma in a patient taking imatinib for GIST: a case report and discussion of risk with other chemotherapeutics.Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme.Gait-simulating fatigue loading analysis and sagittal alignment failure of spinal pelvic reconstruction after total sacrectomy: comparison of 3 techniques.
P50
Q27006955-67135B1B-167C-4670-AD65-2B31A7A2A0A9Q28083956-B8C86A38-EA1B-4AB3-8062-8F0A49ECB60EQ28257733-6488EC0D-14F3-44F9-9F2C-A78AF18E6DD6Q28290345-6E18AB46-9EC6-4DCD-A8A0-A920F6C28854Q30478116-22D1BD52-1CAB-4F3B-B7B4-FC151725A02BQ30685344-A46E44DF-0017-460B-9062-828AF62F9E0CQ30890385-3EB3D5E6-073A-496E-9123-D520F097025EQ31143137-A35442A0-7DF5-458E-BC11-89A7C1A0FAF7Q33275453-E8B48B8B-3AAC-434B-AD05-81C34AB4B012Q33574853-FD71ECFF-911F-4AFF-9BF7-FF5D1BC1C5B9Q34645287-139763FF-C4DE-4FA7-A210-8CE1C49C37C3Q35373577-F81C9181-2446-4C7D-BA60-CF235C955C72Q36086507-E2F4F8D8-8796-49CA-B90D-572C69EBC96FQ36170009-ECF76590-9795-4322-87A3-1ACF4C193E16Q36178623-C5662DD6-B447-41CF-A2E1-B3EDE648D28AQ37268869-A8B50DF6-60DA-4F3F-9EC1-2D088289D8FBQ37688088-4F34A856-935F-4CFC-B0A3-9B9C9442715DQ37908358-25CAAB36-7EC1-4188-B259-E0F065C958AFQ38143707-86394A8A-071E-47CF-947E-34A9580BDEADQ38179560-A1C80199-971E-47A7-A0AB-4F073EE6C48AQ38190591-8AADFCD0-6FD2-4916-B889-041AD0B73AB2Q38238266-7AEBF7C7-DB4C-4FA6-9845-A630FA008594Q38713218-7A5279C7-9E17-403D-82CB-70ADA3B8CD50Q38787746-B5ABDE9D-417C-4AA6-A80C-849DD9DCB12CQ38808398-B22D6A46-8E99-4D8F-8F34-BDC09F775C11Q38845930-56C1D89B-FBA4-4816-834E-C84AB01EAFF1Q38958545-15973165-A568-4180-84B2-C7C5F6D79654Q40166180-130294B3-F1AD-4C61-8B77-A8E45E0E4BE3Q41655425-DE514D2E-4003-4FA8-B0AB-755298C63304Q43674694-B3436991-67A0-41F4-B606-539483D0F8F5Q45217539-70B4C599-83F0-4087-AFE8-EF139D3EAE9DQ45392029-455EE16A-5765-427C-BED4-470827FB736BQ45737936-34918177-BBE6-4724-81A5-62DD5D58375EQ45830520-60B8C9F4-04AA-4D6B-B28C-929CE19CAD86Q46008335-5279593F-50F1-4A55-B89A-4D26FD8DBFC6Q46482972-5949828C-56DD-4255-B80A-C4328E6B31F5Q47406731-4AEA29BB-ED47-4500-86A3-3E37CE6A9B04Q52145638-B1DB2543-E7C7-4CE0-AFF5-36A5A1DC304AQ52646452-E6D2ED03-8E81-463D-8126-D8B5705463F2Q53633386-62412127-0378-491F-9186-1A4D19201208
P50
description
researcher ORCID ID = 0000-0002-4798-4989
@en
name
Michael E Ivan
@ast
Michael E Ivan
@en
Michael E Ivan
@es
Michael E Ivan
@nl
type
label
Michael E Ivan
@ast
Michael E Ivan
@en
Michael E Ivan
@es
Michael E Ivan
@nl
prefLabel
Michael E Ivan
@ast
Michael E Ivan
@en
Michael E Ivan
@es
Michael E Ivan
@nl
P1153
36015318300
P21
P31
P496
0000-0002-4798-4989